文献速递泌尿生殖腹部MR

能否不做手术预测病理状态?多参数MRI与全前列腺影像组学在整合机器学习模型中的附加价值评估

Can we predict pathology without surgery? Weighing the added value of multiparametric MRI and whole prostate radiomics in integrative machine learning models.
PubMed 文献 · Eur Radiol · 2024-03-20

本研究基于单中心949例2015至2018年接受多参数MRI及前列腺切除术的患者,用梯度提升决策树模型分别以临床特征、临床联合影像报告和/或前列腺影像组学特征预测病理T分期、病理N分期、ISUP评分及其较临床前评估的变化。包含全部变量的模型表现最佳,六个终点AUC为0.73至0.96,影像组学特征带来小幅但可测量的性能提升,最佳模型优于临床基线(p≤0.0001),假阴性预测显著减少且总体较少发生分期低估。

要点

  • 含临床、影像报告与影像组学特征的整合模型对六个病理终点的AUC为0.73至0.96。
  • 影像组学特征带来小幅但可测量的性能提升,SHAP值提示其对个体患者预测可起关键作用。
  • 最佳模型优于临床基线(p≤0.0001),假阴性预测显著减少,总体较少发生分期低估。

核心结论

  • 整合机器学习模型对前列腺癌病理状态预测具有潜在获益,最佳模型较少发生分期低估,其提高的病理预测准确性可能成为临床工作流程的助力。

研究设计与样本

  • 单中心队列研究,纳入2015至2018年在本机构接受多参数MRI和前列腺切除术的患者共949例,采用梯度提升决策树模型分别以临床特征单独及联合影像报告和/或前列腺影像组学特征训练,预测病理T、病理N、ISUP评分及其较临床前评估的变化。

诊断标准与关键数值

  • 含全部变量的模型表现最佳,六个终点AUC为0.73至0.96;最佳模型优于临床基线(p≤0.0001);低风险患者的平均绝对误差较低。

临床应用与阅片要点

  • 作者认为此类整合机器学习模型可能为治疗前提供准确的病理预测,从而助力临床工作流程;原文未据此给出具体阅片或报告操作推荐。

局限性

  • 原文未报告局限性;作者在结论中提出尚需关于此类模型临床整合的进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To test the ability of high-performance machine learning (ML) models employing clinical, radiological, and radiomic variables to improve non-invasive prediction of the pathological status of prostate cancer (PCa) in a large, single-institution cohort.

METHODS: Patients who underwent multiparametric MRI and prostatectomy in our institution in 2015-2018 were considered; a total of 949 patients were included. Gradient-boosted decision tree models were separately trained using clinical features alone and in combination with radiological reporting and/or prostate radiomic features to predict pathological T, pathological N, ISUP score, and their change from preclinical assessment. Model behavior was analyzed in terms of performance, feature importance, Shapley additive explanation (SHAP) values, and mean absolute error (MAE). The best model was compared against a naïve model mimicking clinical workflow.

RESULTS: The model including all variables was the best performing (AUC values ranging from 0.73 to 0.96 for the six endpoints). Radiomic features brought a small yet measurable boost in performance, with the SHAP values indicating that their contribution can be critical to successful prediction of endpoints for individual patients. MAEs were lower for low-risk patients, suggesting that the models find them easier to classify. The best model outperformed (p ≤ 0.0001) clinical baseline, resulting in significantly fewer false negative predictions and overall was less prone to under-staging.

CONCLUSIONS: Our results highlight the potential benefit of integrative ML models for pathological status prediction in PCa. Additional studies regarding clinical integration of such models can provide valuable information for personalizing therapy offering a tool to improve non-invasive prediction of pathological status.

CLINICAL RELEVANCE STATEMENT: The best machine learning model was less prone to under-staging of the disease. The improved accuracy of our pathological prediction models could constitute an asset to the clinical workflow by providing clinicians with accurate pathological predictions prior to treatment.

KEY POINTS: • Currently, the most common strategies for pre-surgical stratification of prostate cancer (PCa) patients have shown to have suboptimal performances. • The addition of radiological features to the clinical features gave a considerable boost in model performance. Our best model outperforms the naïve model, avoiding under-staging and resulting in a critical advantage in the clinic. •Machine learning models incorporating clinical, radiological, and radiomics features significantly improved accuracy of pathological prediction in prostate cancer, possibly constituting an asset to the clinical workflow.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Marvaso G, Isaksson LJ, Zaffaroni M, et al. Can we predict pathology without surgery? Weighing the added value of multiparametric MRI and whole prostate radiomics in integrative machine learning models. Eur Radiol. 2024. PMID: 38507053. doi:10.1007/s00330-024-10699-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。